BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31837651)

  • 1. Is standard radical surgery necessary for elderly patients with early-stage epithelial ovarian carcinoma? ~Propensity score matched analysis~.
    Kajiyama H; Yoshihara M; Tamauchi S; Yoshikawa N; Niimi K; Suzuki S; Shibata K; Kikkawa F
    Jpn J Clin Oncol; 2020 Apr; 50(4):411-418. PubMed ID: 31837651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~.
    Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Mizuno K; Yamamuro O; Nagasaka T; Shibata K; Kikkawa F
    BMC Cancer; 2019 Dec; 19(1):1235. PubMed ID: 31856753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma.
    Kajiyama H; Suzuki S; Yoshikawa N; Tamauchi S; Shibata K; Kikkawa F
    J Gynecol Oncol; 2020 Jul; 31(4):e47. PubMed ID: 32026661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.
    Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis.
    Ikeda Y; Yoshihara M; Yoshikawa N; Yokoi A; Tamauchi S; Nishino K; Niimi K; Kajiyama H
    BMC Womens Health; 2022 Mar; 22(1):80. PubMed ID: 35313889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncologic outcome and its prognostic indicators in reproductive-age women with ovarian clear-cell carcinoma.
    Kajiyama H; Suzuki S; Yoshikawa N; Niimi K; Kawai M; Shibata K; Kikkawa F
    Arch Gynecol Obstet; 2019 Sep; 300(3):717-724. PubMed ID: 31165243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis.
    Yoshihara M; Tamauchi S; Iyoshi S; Kitami K; Uno K; Tano S; Matsui S; Kajiyama H
    Jpn J Clin Oncol; 2021 Mar; 51(3):387-392. PubMed ID: 33253382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Jpn J Clin Oncol; 2020 Feb; 50(2):145-151. PubMed ID: 31688935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women.
    Johansen G; Dahm-Kähler P; Staf C; Flöter Rådestad A; Rodriguez-Wallberg KA
    BMC Cancer; 2020 Oct; 20(1):1009. PubMed ID: 33076846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of lymph node dissection on apparent Stage I epithelial ovarian carcinoma: A population-based study.
    Chen Q; Wang S; Lang JH
    Int J Gynaecol Obstet; 2021 Sep; 154(3):550-557. PubMed ID: 33507544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes of fertility-sparing surgery in early stage epithelial ovarian cancer: a population-based propensity score-matched analysis.
    Xie Q; Meng X; Liao Q
    Arch Gynecol Obstet; 2022 Nov; 306(5):1679-1688. PubMed ID: 35364698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of uterus-preserving surgery on Stage I primary mucinous epithelial ovarian carcinoma: A multi-institutional study with propensity score-weighted analysis.
    Yoshihara M; Kajiyama H; Tamauchi S; Iyoshi S; Yokoi A; Suzuki S; Kawai M; Nagasaka T; Takahashi K; Matsui S; Kikkawa F
    Int J Gynaecol Obstet; 2020 Aug; 150(2):177-183. PubMed ID: 32469080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma.
    Nasioudis D; Mulugeta-Gordon L; McMinn E; Byrne M; Ko EM; Cory L; Haggerty AF; Latif NA
    Int J Gynecol Cancer; 2021 Mar; 31(3):480-483. PubMed ID: 33649017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.
    Kajiyama H; Suzuki S; Niimi K; Tamauchi S; Kawai M; Nagasaka T; Shibata K; Kikkawa F
    Int J Clin Oncol; 2019 Jul; 24(7):857-862. PubMed ID: 30771039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma.
    Hsieh SF; Lau HY; Wu HH; Hsu HC; Twu NF; Cheng WF
    Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30795566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database.
    Nasioudis D; Mastroyannis SA; Ko EM; Haggerty AF; Cory L; Giuntoli RL; Kim SH; Morgan MA; Latif NA
    Gynecol Oncol; 2022 Aug; 166(2):263-268. PubMed ID: 35667901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.
    Mallen A; Todd S; Robertson SE; Kim J; Sehovic M; Wenham RM; Extermann M; Chon HS
    Gynecol Oncol; 2021 Jun; 161(3):693-699. PubMed ID: 33812698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study.
    Gallotta V; Petrillo M; Conte C; Vizzielli G; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Carbone V; Scambia G
    J Minim Invasive Gynecol; 2016; 23(5):769-74. PubMed ID: 26995493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
    J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
    Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
    Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.